2024-02-04 15:24:06
LONDON, March 21, 2021 /PRNewswire/ — Accord Healthcare (Accord), one of Europe’s fastest growing pharmaceutical companies, is taking part in a newscast for ITN Business today on World Cancer Day 2024, alongside other industry and patient community partners in a mission United to raise awareness of the importance of collaboration to improve health outcomes and shape the future of cancer care.
Hosted by presenter Simon Thomas from ITN’s London studios, the show looks at the cutting-edge research and health technologies leading the way in preventing, detecting and treating cancer, as well as early diagnosis and a collaborative approach represent the key to a better future for patients.
One person is diagnosed with cancer every two minutes in the UK and one in two people will be diagnosed with some form of cancer during their lifetime[1].
Accord’s film shows how we contribute to the fight against cancer by highlighting our heritage as an oncology medicines company with our generics portfolio and how the company looks to the future by bringing new and innovative medicines to market to treat the disease to fight.
The program also highlights how Accord, working with NHS England and the MHRA, has played a leading role in repurposing older medicines for new patient cohorts.
Joseph Dunford, VP of Specialty Brands, Accord Healthcare EMENA said
“Given that so many of us are affected by cancer, this was a really important and poignant program to be a part of. Only through collaboration between cancer experts, industry, academia and patient organizations can we make real progress towards a world without cancer.”
“There’s a lot of positive things to say, but more needs to be done and World Cancer Day is a fantastic moment to raise awareness while recognizing the great work being done.”
“Shaping the Future of Cancer Care” launches on February 4, 2024 on the occasion of World Cancer Day and will be available exclusively online at
About Accord Healthcare
Accord Healthcare is headquartered in the UK and is one of the fastest growing pharmaceutical companies in Europe. Accord has one of the largest market presences of any European generics and biosimilars company, distributing generics in over 80 countries around the world. This global presence allows us to deliver vital, affordable medicines to national health systems and support healthcare workers to improve the lives of patients worldwide.
Accord’s approach is agile and inventive, always with the aim of improving products and patient access to them. Accord is committed to thinking differently and doing more to benefit patients worldwide.
Information about ITN Business
Building on decades of experience in B2B and corporate communications, ITN Business works with organizations, companies and brands to create a deeper, more authentic connection with their employees, customers, partners, investors or the world. Industry News is our broadcast news-style program and tailored digital campaigns for sectors, charities and industries where we report on innovation, best practice and thought leadership to connect with the audiences that matter to our clients and ensure longer-term impact. For more information visit: business.itn.co.uk
[1] OECD, Health at Glance 2022, European Commission
View original content: lten-302052662.html
Questions & Contact:
Nick Johnson – Director of Public Relations and Communications pr@accord-health.com,
+447435220822
1707062851
#mark #World #Cancer #Day #Accord #Healthcare #partnering #ITN #Business #explore #innovative #approaches #helping #shape #future #cancer #care